New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 18, 2012
10:00 EDTPJC, SYK, SKUL, EIX, SWK, QUAD, STJ, HAL, CSX, RDS.A, DB, ABT, POT, CMAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abbott (ABT) downgraded to Market Perform from Outperform at Raymond James... CSX (CSX) downgraded to Hold from Buy at Deutsche Bank... Comerica (CMA) downgraded to Neutral from Buy at Sterne Agee... Deutsche Bank (DB) downgraded to Underweight from Neutral at JPMorgan... Halliburton (HAL) downgraded to Equal Weight from Overweight at Stephens... Potash (POT) downgraded to Sector Perform from Outperform at RBC Capital... Royal Dutch Shell (RDS.A) downgraded to Sell from Neutral at Goldman... Skullcandy (SKUL) downgraded to Market Perform from Strong Buy at Raymond James... St. Jude Medical (STJ) downgraded to Hold from Buy at Canaccord...Stanley Black & Decker (SWK) downgraded to Market Perform from Outperform at Raymond James... Stryker (SYK) downgraded to Perform from Outperform at Oppenheimer... Quad/Graphics (QUAD) downgraded to Underperform at Sector Perform at RBC Capital... Edison International (EIX) downgraded to Neutral from Buy at Citigroup... Piper Jaffray (PJC) downgraded to Hold from Buy at Sandler O'Neill.
News For A;SKUL;STJ;SWK;SYK;QUAD;EIX;PJC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 18, 2015
16:07 EDTAAgilent sees Q3 EPS 38c-42c, consensus 42c
Sees Q3 revenue $995M-$1.015B, consensus $1B.
16:06 EDTAAgilent reports Q2 EPS 38c, consensus 39c
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
07:19 EDTSWKElectric Products Group to hold a conference
EPG 2015 is being held in Longboat Key, Florida on May 18-20 with webcasted company presentations to begin on May 18 at 7:30 am; not all company presentations may be webcasted. Webcast Link
May 15, 2015
14:20 EDTSTJSt. Jude Medical reports positive results from CardioMEMS HF System
Subscribe for More Information
14:01 EDTSTJSt. Jude Medical reports positive results from Allure Quadra CRT-P System
St. Jude Medical announced the presentation of important data supporting the first and only quadripolar cardiac resynchronization therapy pacemaker system in the U.S., during the Heart Rhythm Society's 36th annual scientific sessions. The Allure Quadra CRT-P system, with the Quartet Quadripolar LV Lead is associated with a 63% reduction in the need to replace the lead or deactivate CRT following implant. Quadripolar LV pacing using SJM quadripolar CRT-Ds or CRT-Ps and an SJM quadripolar lead provides physicians with multiple pacing options to avoid phrenic nerve stimulation and allow for optimal treatment delivery without the need to replace or deactivate the therapy. An analysis evaluating more than 3,000 patients implanted with a CRT-P (1,325 with a quadripolar lead vs. 1,930 with a bipolar lead) looked at whether the known decreased need to replace or deactivate LV leads associated with SJM quadripolar CRT-Ds and the Quartet LV lead also extends to St. Jude Medical quadripolar CRT-Ps. The retrospective data analysis was presented in a session titled Quadripolar Leads are Associated with Fewer LV Lead Replacements and Deactivations in CRT-P Patients by Dr. Mintu P. Turakhia, who led the investigation. The data show that patients with the Quartet LV lead were 63% less likely to undergo lead replacement or deactivation of CRT compared to the patients with bipolar leads.
12:39 EDTEIXWells identifies NextEra, Sempra as among favorite utility names
Utilities as a group have dropped in recent months and there are several names in the sector that offer relative value and exposure to secular growth trends, Wells Fargo stated in a note to investors today. WHAT'S NEW: The utilities sector is trading at a forward multiple that is 93% of the S&P 500, versus the ten year average of 102%, according to Wells. Moreover, utilities are "slightly cheap" relative to interest rates, the firm thinks. NextEra Energy (NEE) and Sempra Energy (SRE) have the best growth opportunities in the utility space, according to Wells. They also have proven management teams and are well-positioned to exploit long-term trends, including renewable energy and energy infrastructure, the firm believes. ITC Holdings (ITC) has reached an attractive entry point and, to a degree, offers a near-term hedge against an interest rate increase, according to the firm. Edison International (EIX) and Xcel Energy (XEL) are underappreciated regulated utilities, added Wells. Edison trades in-line with its peers despite superior EPS growth potential and Xcel trades at a 3%-6% discount to the sector despite its at least in-line EPS growth and comparable regulatory risk, which might ease, the firm added. PRICE ACTION: In early afternoon trading, NextEra rose 0.5%, Sempra gained 0.6%, Edison added 0.6%, Xcel climbed 0.4% and ITC was little changed.
10:29 EDTSYKAmerican Urological Association to hold an annual meeting
Subscribe for More Information
08:45 EDTSTJSt. Jude Medical management to meet with Leerink
Subscribe for More Information
08:41 EDTSTJSt. Jude Medical management to meet with Leerink
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
07:49 EDTEIXWells Fargo identifies favorite utility names
Wells Fargo says that NextEra Energy (NEE) and Sempra Energy (SRE) have the best growth opportunities in the utility space as well as proven management teams, and are well-positioned to exploit long-term trends. ITC Holdings (ITC) has reached an attractive entry point, and, to a degree, offers a near-term hedge against an interest rate increase, according to the firm. Edison International (EIX) and Xcel Energy (XEL) are underappreciated regulated utilities, added Wells.
May 14, 2015
13:54 EDTSYKStryker initiated with an Outperform at Northland
Subscribe for More Information
09:41 EDTSTJLeerink medical devices analyst holds a cardiology luncheon meeting
Subscribe for More Information
May 13, 2015
08:08 EDTAAgilent volatility elevated into Q1 and sales outlook
Subscribe for More Information
08:08 EDTSTJSt. Jude Medical receives CE Mark approval of Ellipse expanded labeling
Subscribe for More Information
07:31 EDTSTJ, SYKHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
May 12, 2015
11:43 EDTSYKStryker backs FY15 organic revenue growth of 5%-6%
Subscribe for More Information
07:35 EDTSTJBofA/Merrill to hold a conference
Subscribe for More Information
May 10, 2015
12:54 EDTEIXDuke, Edison, other utilities could return 8% annually, Barron's says
Shares of Duke Energy (DUK), Southern Company (SO), Consolidated Edison (ED), Edison International (EIX), PG&E (PCG), American Electric (AEP), Dominion (D), and NextEra Energy (NEE) could return 8% or more annually in coming years, Barron's contends in a feature article. Though utilities are sometimes seen as no-growth businesses, Barron's argues that infrastructure replacement projects, rate hikes, and dividend boosts make the sector look attractive. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use